Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 324

    1.

    Implications for risk assessment of suggested nongenotoxic mechanisms of chemical carcinogenesis.

    Melnick RL, Kohn MC, Portier CJ.

    Environ Health Perspect. 1996 Mar;104 Suppl 1:123-34. Review.PMID: 8722116 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Nongenotoxic carcinogens: development of detection methods based on mechanisms: a European project.

    Yamasaki H, Ashby J, Bignami M, Jongen W, Linnainmaa K, Newbold RF, Nguyen-Ba G, Parodi S, Rivedal E, Schiffmann D, Simons JW, Vasseur P.

    Mutat Res. 1996 Jun 12;353(1-2):47-63. Review.PMID: 8692192 [PubMed - indexed for MEDLINE]Related articles

    3.

    Implications of multiple mechanisms of carcinogenesis for short-term testing.

    Harper BL, Morris DL.

    Teratog Carcinog Mutagen. 1984;4(6):483-503.PMID: 6151260 [PubMed - indexed for MEDLINE]Related articles

    4.

    Carcinogenic risks of dioxin: mechanistic considerations.

    Schwarz M, Appel KE.

    Regul Toxicol Pharmacol. 2005 Oct;43(1):19-34. Review.PMID: 16054739 [PubMed - indexed for MEDLINE]Related articles

    6.

    Liver carcinogenesis is not a predicted outcome of chemically induced hepatocyte proliferation.

    Melnick RL, Huff J.

    Toxicol Ind Health. 1993 May-Jun;9(3):415-38. Review.PMID: 8367884 [PubMed - indexed for MEDLINE]Related articles

    7.

    Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?

    Gaylor DW.

    Regul Toxicol Pharmacol. 2005 Mar;41(2):128-33. Epub 2004 Dec 19.PMID: 15698536 [PubMed - indexed for MEDLINE]Related articles

    9.

    Environmental and chemical carcinogenesis.

    Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

    Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.PMID: 15489140 [PubMed - indexed for MEDLINE]Related articles

    10.

    Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.

    Bolt HM, Foth H, Hengstler JG, Degen GH.

    Toxicol Lett. 2004 Jun 15;151(1):29-41. Review.PMID: 15177638 [PubMed - indexed for MEDLINE]Related articles

    11.

    Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).

    Chevalier S, Roberts RA.

    Oncol Rep. 1998 Nov-Dec;5(6):1319-27. Review.PMID: 9769363 [PubMed - indexed for MEDLINE]Related articles

    12.

    Active cell death (apoptosis) and cellular proliferation as indicators of exposure to carcinogens.

    Schulte-Hermann R, Bursch W, Marian B, Grasl-Kraupp B.

    IARC Sci Publ. 1999;(146):273-85. Review.PMID: 10353391 [PubMed - indexed for MEDLINE]Related articles

    13.

    Types and amounts of carcinogens as potential human cancer hazards.

    Weisburger JH, Williams GM.

    Cell Biol Toxicol. 1989 Dec;5(4):377-91.PMID: 2627674 [PubMed - indexed for MEDLINE]Related articles

    14.

    A comprehensive approach for integration of toxicity and cancer risk assessments.

    Butterworth BE, Bogdanffy MS.

    Regul Toxicol Pharmacol. 1999 Feb;29(1):23-36. Review.PMID: 10051416 [PubMed - indexed for MEDLINE]Related articles

    15.

    Prediction of rodent nongenotoxic carcinogenesis: evaluation of biochemical and tissue changes in rodents following exposure to nine nongenotoxic NTP carcinogens.

    Elcombe CR, Odum J, Foster JR, Stone S, Hasmall S, Soames AR, Kimber I, Ashby J.

    Environ Health Perspect. 2002 Apr;110(4):363-75.PMID: 11940454 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Mechanisms of multistep carcinogenesis and carcinogen risk assessment.

    Barrett JC.

    Environ Health Perspect. 1993 Apr;100:9-20. Review.PMID: 8354184 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Mouse liver tumor data: assessment of carcinogenic activity.

    Pereira MA.

    Toxicol Ind Health. 1985 Dec;1(4):311-33.PMID: 3843510 [PubMed - indexed for MEDLINE]Related articles

    18.

    Epigenetic carcinogens: evaluation and risk assessment.

    Williams GM, Whysner J.

    Exp Toxicol Pathol. 1996 Feb;48(2-3):189-95. Review.PMID: 8672874 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.

    Fukushima S, Kinoshita A, Puatanachokchai R, Kushida M, Wanibuchi H, Morimura K.

    Carcinogenesis. 2005 Nov;26(11):1835-45. Epub 2005 Jun 23. Review.PMID: 15975961 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).

    National Toxicology Program.

    Natl Toxicol Program Tech Rep Ser. 2006 Jan;(520):4-246.PMID: 16628245 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data